FDA NAMES 11 PHYSICIANS TO ADVISORY COMMITTEE
FOR REPRODUCTIVE HEALTH DRUGS

FDA Commissioner Mark B. McClellan, M.D., today named 11 physicians to the agency's Advisory Committee for Reproductive Health Drugs.

The committee will be chaired by Dr. Linda C. Giudice, M.D., Ph.D., the chief of reproductive endocrinology and infertility for the Department of Gynecology and Obstetrics at the Stanford University Medical Center.

"Each of these 11 physicians brings strong scientific and medical backgrounds to this important advisory group," FDA Commissioner Mark McClellan, M.D., said. "Under Dr. Giudice's stewardship, this panel will provide sound, science-based advice on reproductive health issues that will improve women's lives across the country."

At the request of the FDA, the advisory committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drugs for use in the practice of obstetrics, gynecology and related specialties, and makes appropriate recommendations to the FDA.

While the committee is an existing FDA advisory committee, its entire membership had lapsed and it had not met for two years. One of the first issues the committee will examine is the issue of hormone therapy, which has come under increased attention with the release of several new studies questioning its safety and effectiveness.

The other 10 members of the committee are:

• Leslie Gay Bernitsky, M.D., an urologist from Albuquerque, N.M.
• Susan A. Crockett, M.D., a clinical assistant professor at the University of Texas Health Science Center at San Antonio and director of maternity services at Christus Santa Rosa Hospital.
• Nancy Dickey, M.D., the chancellor of the Texas A&M College of Medicine and the immediate past president of the American Medical Association. Dr. Dickey practices family medicine.
• Scott Shields Emerson, M.D., Ph.D, a professor in the Department of Biostatistics at the University of Washington in Seattle.
• Michael Furman Greene, M.D., director of Maternal-Fetal Medicine at Massachusetts General Hospital in Boston.
• W. David Hager, M.D., a professor of obstetrics and gynecology at the University of Kentucky College of Medicine in Lexington, Ky.
• Vivian Lewis, M.D., an associate professor of clinical obstetrics and gynecology and director of the Division of Reproductive Endocrinology at the University of Rochester Medical Center in Rochester, N.Y.
• George A. Marcones, M.D., M.S.C.E., a statistician and professor in the Division of Maternal-Fetal Medicine at the University of Pennsylvania in Philadelphia.
• Valerie Montgomery Rice, M.D., a reproductive endocrinologist at the University of Kansas Medical Center in Kansas City, Kan.
• Joseph Barney Stanford, M.D., M.S.P.H., an associate professor, Department of Family and Preventive Medicine at the University of Utah in Salt Lake City.
  

####

Media Contacts   |   FDA News Page   |   FDA Home Page

Office of Public Affairs
Web page uploaded by tg 2002-DEC-24.